Skip to main content
    C

    Codexis Inc (CDXS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.07
    +0.01 (+0.94%)

    Market Cap: $116.17M

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Codexis Inc (CDXS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Codexis (CDXS) has a market cap of $116.17M and an enterprise value of $159.27M. Its share count is up 18.85% from a year earlier. Revenue grew 66.89% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 37.10% above the market cap, as debt exceeds cash.

    Market Cap$116.17M
    Enterprise Value$159.27M
    Latest price (Nov 17, 2026)$1.07

    Key Dates

    The next earnings report is expected on Mar 9, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 9, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 17.80% in the quarter ended Sep 30, 2026 and grew 22.03% a year over 2 years.

    Shares Outstanding107.26M
    Shares Change (YoY)+18.85%
    Shares Change (QoQ)+17.80%
    Share Count Growth (2Y CAGR)+22.03%

    Valuation Ratios

    Forward P/S1.6x
    P/B Ratio2.2x
    P/TBV Ratio2.4x

    Price Statistics

    The stock is down 34.95% over 52 weeks and trades 16.41% below its 50-day average.

    Beta (1Y)1.65
    52-Week Change-34.95%
    1-Month Change-18.94%
    3-Month Change-33.13%
    6-Month Change-56.50%
    5-Year Change-96.58%
    10-Year Change-76.44%
    Total Return (1Y)-34.95%
    Total Return (3Y CAGR)-19.35%
    Total Return (5Y CAGR)-50.84%
    Return vs SPY (1Y)-46.32%
    Max Drawdown (1Y)-66.38%
    Max Drawdown (3Y)-83.51%
    Sharpe Ratio (1Y)-0.50
    Correlation with SPY (1Y)0.26
    50-Day Average$1.28
    200-Day Average$1.79
    52-Week Range$0.90 to $2.98
    RSI (14 Days)43.6
    Average Volume (20 Days)950.56K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.81x current liabilities, and total debt is 1.41x shareholder equity.

    Current Ratio2.81x
    Quick Ratio2.75x
    Debt / Equity1.41x

    Returns and Efficiency

    ROE (5Y Average)-61.75%
    ROA (5Y Average)-30.29%
    ROIC (5Y Average)-79.36%
    Asset Turnover0.66x

    Scores

    CDXS has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $88.34M over the last 12 months.

    Revenue$88.34M
    Revenue Growth (YoY)+66.89%
    Gross Profit$75.39M
    Operating Income-$12.74M
    Pretax Income-$19.16M
    Net Income-$19.24M
    EBITDA-$11.15M
    Reported EPS (TTM)-$0.17

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 35.53% of the $144.22M in total assets.

    Cash and Equivalents$29.21M
    Total Debt$72.31M
    Net Debt$43.10M
    Net Debt Per Share$0.40
    Working Capital$61.67M
    Shareholder Equity$51.24M
    Book Value Per Share$0.48
    Tangible Book Value$48.77M
    Tangible Book Per Share$0.45
    Total Assets$144.22M
    Total Liabilities$92.98M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.67M of capital spending, operating cash flow left -$12.14M of free cash flow.

    Operating Cash Flow-$10.47M
    Capital Expenditures$1.67M
    Free Cash Flow-$12.14M
    FCF Per Share-$0.11
    Depreciation and Amortization$9.72M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -14.42%, against a 5-year average of -59.39%.

    Gross Margin85.34%
    Operating Margin-14.42%
    Pretax Margin-21.69%
    Net Margin-21.77%
    EBITDA Margin-12.62%
    FCF Margin-13.74%
    Gross Margin (5Y Average)78.48%
    Operating Margin (5Y Average)-59.39%
    Net Margin (5Y Average)-65.14%

    Growth

    Revenue fell 20.22% a year over 3 years.

    Revenue Growth (3Y CAGR)-20.22%
    Revenue Growth (5Y CAGR)+0.38%
    Book Value Per Share Growth (2Y CAGR)-33.22%
    Tangible Book Per Share Growth (2Y CAGR)-33.92%

    Revenue and profit by year

    Analyst Forecast

    Consensus estimates put revenue growth at 11.63% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+11.63%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About CDXS

    What is CDXS's market cap?

    Codexis has a market cap of $116.17M. Its enterprise value, which adds debt and subtracts cash, is $159.27M.

    How many shares of CDXS are outstanding?

    Codexis has 107.26M shares outstanding. The count is up 18.85% from a year earlier.

    Does CDXS pay a dividend?

    No. Codexis does not pay a dividend.

    How much debt does CDXS have?

    Codexis has $72.31M of total debt and $29.21M of cash and equivalents, a net debt position of $43.10M.